Skip to main content

Table 1 Clinical characteristics of the patients with tuberculous pleurisy

From: In-hospital outcome of patients with culture-confirmed tuberculous pleurisy: clinical impact of pulmonary involvement

  Isolated pleurisy group (N = 51) Pleuro-pulmonary group (N = 154) p value
Age (years) 52.6 [27.7] 70.4 [16.5] < 0.001
Age ≥ 65 years 23 (43%) 114 (74%) < 0.001
Male gender 35 (69%) 114 (74%) 0.453
Underlying co-morbid condition* 14 (27%) 72 (47%) 0.015
   Diabetes mellitus 4 (8%) 27 (18%) 0.118
   Malignancy 7 (14%) 22 (14%) 0.921
   Renal failure 3 (6%) 16 (10%) 0.575
   Cirrhosis of liver 2 (4%) 7 (5%) 1.000
   Autoimmune diseases 0 7 (5%) 0.198
   Acquired immunodeficiency syndrome# 1 (2%) 5 (3%) 1.000
Symptoms    
   Duration, days 17.8 [31.0] 17.3 [27.4] 0.923
   Cough 2 (4%) 19 (12%) 0.112
   Fever 26 (51%) 43 (28%) 0.002
   Dyspnea 13 (25%) 51 (33%) 0.360
   Chest pain 6 (12%) 3 (2%) 0.007
   Others† 4 (8%) 38 (25%) 0.010
  1. Data are no. (%) or mean [SD]
  2. * Three and twelve in the isolated pleurisy group and pleuro-pulmonary group, respectively, had two underlying co-morbid conditions.
  3. † Other symptoms included gastrointestinal symptoms, consciousness change and other non-specific symptoms.
  4. # 63 patients received human immunodeficiency tests.